European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.
暂无分享,去创建一个
R Holland | N Perry | C. de Wolf | R. Holland | M. Broeders | N. Perry | S. Törnberg | L. von Karsa | S Törnberg | M Broeders | C de Wolf | L von Karsa
[1] K. Siziopikou,et al. Rosen's Breast Pathology , 2009 .
[2] S. Holm. Informed Consent: Ethical and Legal Issues , 2009 .
[3] A. Sahin,et al. Mucinous Lesions of the Breast. , 2009, Surgical pathology clinics.
[4] C. Quinn,et al. Columnar cell lesions of the breast , 2007, Histopathology.
[5] J. Ferlay,et al. Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] Ehsan Samei,et al. Assessment of display performance for medical imaging systems: executive summary of AAPM TG18 report. , 2005, Medical physics.
[7] A. Vincent-Salomon,et al. Histological margin assessment for breast ductal carcinoma in situ: precision and implications , 2004, Modern Pathology.
[8] J. Wesseling,et al. Axillary recurrence after sentinel lymph node biopsy. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[9] K. Kahn,et al. Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Piccart,et al. The Hamburg statement: the partnership driving the European agenda on breast cancer. , 2004, European Journal of Cancer.
[11] S. Ciatto,et al. Prognostic impact of the early detection of metachronous contralateral breast cancer. , 2004, European journal of cancer.
[12] J. Peterse,et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology , 2004, Journal of Clinical Pathology.
[13] D. Giorgi,et al. Monitoring surgical treatment of screen-detected breast lesions in Italy. , 2004, European journal of cancer.
[14] G. Cserni. A model for determining the optimum histology of sentinel lymph nodes in breast cancer , 2004, Journal of Clinical Pathology.
[15] S. Barni,et al. Effects of media information on cancer patients' opinions, feelings, decision‐making process and physician‐patient communication , 2004, Cancer.
[16] R Holland,et al. Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions , 2004, British Journal of Cancer.
[17] J. Hoffmann. Is it time for a paradigm shift in the training of breast surgeons as a sub-speciality? , 2004, Breast.
[18] A. Gown,et al. Accuracy and precision in HER2/neu testing in breast cancer: are we there yet? , 2004, Human pathology.
[19] A. Hanby,et al. Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained , 2004, Journal of Clinical Pathology.
[20] Peter C Gøtzsche,et al. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study , 2004, BMJ : British Medical Journal.
[21] C. Theisen. In different cultures, cancer screening presents challenges. , 2004, Journal of the National Cancer Institute.
[22] L. Sobin,et al. Classification of isolated tumor cells , 2003, Cancer.
[23] M. Buchanan. The role of women's advocacy groups in breast cancer. , 2003, Breast.
[24] Per Skaane,et al. Population-based mammography screening: comparison of screen-film and full-field digital mammography with soft-copy reading--Oslo I study. , 2003, Radiology.
[25] Karla Kerlikowske,et al. Comparison of screening mammography in the United States and the United kingdom. , 2003, JAMA.
[26] C. Baines. Mammography screening: are women really giving informed consent? , 2003, Journal of the National Cancer Institute.
[27] J. Carr,et al. Biopsy Needle Technique and the Accuracy of Diagnosis of Atypical Ductal Hyperplasia for Mammographic Abnormalities , 2003, The American surgeon.
[28] J. Peterse,et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. , 2003, European journal of cancer.
[29] Byllye Y. Avery,et al. The road to advocacy--searching for the rainbow. , 2003, American journal of public health.
[30] P. Adab,et al. Randomised controlled trial of the effect of evidence based information on women’s willingness to participate in cervical cancer screening , 2003, Journal of epidemiology and community health.
[31] A. Edwards,et al. Women need better information about routine mammography , 2003, BMJ : British Medical Journal.
[32] M. Baum. Is it time for a paradigm shift in the training of breast surgeons as a sub-speciality?! , 2003, Breast.
[33] A. Vincent-Salomon,et al. Columnar Cell Lesions of the Breast , 2003, Advances in anatomic pathology.
[34] L J Schultze Kool,et al. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. , 2003, European journal of cancer.
[35] M. Hammond,et al. Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice. , 2003, Archives of pathology & laboratory medicine.
[36] A. Vincent-Salomon,et al. Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS * Study , 2003, Histopathology.
[37] J. Bartlett,et al. The clinical evaluation of HER‐2 status: which test to use? , 2003, The Journal of pathology.
[38] M. Dowsett,et al. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres , 2003, The Journal of pathology.
[39] E. Zanon,et al. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management , 2003, British Journal of Cancer.
[40] E. Cronin,et al. Invasive Mammary Carcinoma After Immediate and Short-Term Follow-up for Lobular Neoplasia on Core Biopsy , 2003, The American journal of surgical pathology.
[41] M. Dowsett,et al. Current Perspectives on HER2 Testing: A Review of National Testing Guidelines , 2003, Modern Pathology.
[42] I. Ellis,et al. Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast Carcinoma , 2003, The American journal of surgical pathology.
[43] G. Lawrence,et al. The National Health Service Breast Screening Programme and British Association of Surgical Oncology audit of quality assurance in breast screening 1996–2001 , 2003, The British journal of surgery.
[44] P. Butow,et al. Medical tests: women's reported and preferred decision‐making roles and preferences for information on benefits, side‐effects and false results , 2002, Health expectations : an international journal of public participation in health care and health policy.
[45] W. P. Evans,et al. Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary? , 2002, AJR. American journal of roentgenology.
[46] M. Risio,et al. HER2 testing and correlation with efficacy of trastuzumab therapy. , 2002, Oncology.
[47] I. Ellis,et al. HER-2 in breast cancer--methods of detection, clinical significance and future prospects for treatment. , 2002, Critical reviews in oncology/hematology.
[48] Anthony Rhodes,et al. Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. , 2002, American journal of clinical pathology.
[49] S. Schnitt,et al. Nonmalignant Lesions in Breast Core Needle Biopsies: To Excise or Not to Excise? , 2002, The American journal of surgical pathology.
[50] J. Bartlett,et al. Fluorescence in situ hybridization in paraffin tissue sections , 2002, Molecular biotechnology.
[51] Walter Huda,et al. How good is the ACR accreditation phantom for assessing image quality in digital mammography? , 2002, Academic radiology.
[52] H. Verkooijen. Diagnostic accuracy of stereotactic large‐core needle biopsy for nonpalpable breast disease: Results of a multicenter prospective study with 95% surgical confirmation , 2002, International journal of cancer.
[53] Peter A Kaufman,et al. Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. , 2002, Journal of the National Cancer Institute.
[54] Greg Yothers,et al. Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience. , 2002, Journal of the National Cancer Institute.
[55] G. Bratthauer,et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. , 2002, Human pathology.
[56] Hermann Herbst,et al. Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept , 2002, Laboratory Investigation.
[57] T. Davis,et al. Health Literacy and Cancer Communication , 2002, CA: a cancer journal for clinicians.
[58] Umberto Veronesi,et al. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA , 2002 .
[59] H. de Vries,et al. Tailored versus general information on early detection of cancer: a comparison of the reactions of Dutch adults and the impact on attitudes and behaviors. , 2002, Health education research.
[60] A. Hanby,et al. Mitotic counts provide additional prognostic information in grade II mammary carcinoma , 2002, The Journal of pathology.
[61] M. Bruijnzeels,et al. Intercultural communication in general practice. , 2002, European journal of public health.
[62] C. Ramsay,et al. Mass media interventions: effects on health services utilisation. , 2002, The Cochrane database of systematic reviews.
[63] J. Stinès,et al. Contrôle de qualité : Du conventionnel au numérique , 2002 .
[64] B. Jasani,et al. A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. , 2002, American journal of clinical pathology.
[65] Catherine Kim Ly,et al. SoftCopy Display Quality Assurance Program at Texas Children's Hospital. , 2002, Journal of digital imaging.
[66] M. Greco,et al. Quality control in prophylactic mastectomy for women at high risk of breast cancer. , 2002, European journal of cancer.
[67] K. Dickersin,et al. Newspaper Reporting of Screening Mammography , 2002, Annals of Internal Medicine.
[68] J Austoker,et al. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. , 2001, Journal of public health medicine.
[69] A. Luini,et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma , 2001, Cancer.
[70] J. Going,et al. Scoring nuclear pleomorphism in breast cancer , 2001, Histopathology.
[71] D B Plewes,et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[72] A Coulter. Patient-centered decision making: empowering women to make informed choices. , 2001, Women's health issues : official publication of the Jacobs Institute of Women's Health.
[73] R. Warren,et al. Screening women at high risk of breast cancer on the basis of evidence. , 2001, European journal of radiology.
[74] I. Ellis,et al. Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings , 2001, British Journal of Cancer.
[75] A. Raffle,et al. Information about screening – is it to achieve high uptake or to ensure informed choice? , 2001, Health expectations : an international journal of public participation in health care and health policy.
[76] M. Parker. The ethics of evidence‐based patient choice , 2001, Health expectations : an international journal of public participation in health care and health policy.
[77] A. Sowden,et al. Increasing informed uptake and non‐uptake of screening: evidence from a systematic review , 2001, Health expectations : an international journal of public participation in health care and health policy.
[78] S. Sonnad,et al. Mammography messages in popular media: implications for patient expectations and shared clinical decision‐making , 2001, Health expectations : an international journal of public participation in health care and health policy.
[79] H A Lehr,et al. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. , 2001, American journal of clinical pathology.
[80] D. Page,et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. , 2001, Human pathology.
[81] P. Rosen. Rosen's Breast Pathology , 2001 .
[82] S. Schnitt. Breast Cancer in the 21st Century: Neu Opportunities and Neu Challenges , 2001, Modern Pathology.
[83] L. Bobrow,et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. , 2001, American journal of clinical pathology.
[84] N. Perry. Quality assurance in the diagnosis of breast disease. EUSOMA Working Party. , 2001, European journal of cancer.
[85] Julie Cooke,et al. CLINICAL GUIDELINES FOR BREAST CANCER SCREENING ASSESSMENT , 2001 .
[86] I. Ellis,et al. Recommendations for HER2 testing in the UK , 2000, Journal of clinical pathology.
[87] C. Lee,et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? , 2000, Radiology.
[88] C. J. Kotre,et al. Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol. , 2000, Physics in medicine and biology.
[89] L. Irwig,et al. Telling people about screening programmes and screening test results: how can we do it better? , 2000, Journal of medical screening.
[90] L. Sobin,et al. Classification of isolated tumor cells and micrometastasis , 2000 .
[91] D Barnes,et al. Immunohistochemical detection of steroid receptors in breast cancer: a working protocol , 2000, Journal of clinical pathology.
[92] Richard Sylvester,et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.
[93] B. Cady. A contemporary view of axillary dissection. , 2000, Annals of surgery.
[94] L. Liberman,et al. Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy. , 2000, AJR. American journal of roentgenology.
[95] F. Bull,et al. Are tailored health education materials always more effective than non-tailored materials? , 2000, Health education research.
[96] L Collette,et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[97] A. Luini,et al. Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions. , 2000, Journal of the American College of Surgeons.
[98] G. Soete,et al. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[99] R. Walker. The significance of histological determination of HER-2 status in breast cancer. , 2000, Breast.
[100] R. Grilli,et al. Does provision of an evidence‐based information change public willingness to accept screening tests? , 2000, Health expectations : an international journal of public participation in health care and health policy.
[101] R. M. Wilson. Screening for breast and cervical cancer as a common cause for litigation , 2000, BMJ : British Medical Journal.
[102] E. Frenkel,et al. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays , 2000, Journal of clinical pathology.
[103] A. Wolff,et al. Primary systemic therapy in operable breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[104] A. Hart,et al. Primary axillary radiotherapy as axillary treatment in breast‐conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes , 2000, Cancer.
[105] B. Fowble,et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? , 2000, International journal of radiation oncology, biology, physics.
[106] M. R. del Turco,et al. General Practitioners and Mammographic Screening Uptake: Influence of Different Modalities of General Practitioner Participation , 2000, Tumori.
[107] G. Schwartz,et al. Consensus Conference on the Classification of Ductal Carcinoma of the Breast, April 22–25, 1999 , 2000, The breast journal.
[108] J. Peterse,et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853 , 2000, The Lancet.
[109] R. Prescott,et al. Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial , 2000, The British journal of surgery.
[110] E. Thurfjell,et al. Predictors of non‐attendance in a population‐based mammography screening programme; socio‐demographic factors and aspects of health behaviour , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[111] D. Page,et al. Benign transport of breast epithelium into axillary lymph nodes after biopsy. , 2000, American journal of clinical pathology.
[112] A. Giuliano,et al. Role of sentinel lymph node dissection in breast cancer , 2000, Annals of medicine.
[113] I. Smith,et al. Neoadjuvant chemotherapy for breast cancer , 2000, Annals of medicine.
[114] G. Schwartz,et al. Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. , 2000, Cancer.
[115] B. Cady,et al. The surgeon's role in outcome in contemporary breast cancer. , 2000, Surgical oncology clinics of North America.
[116] A. Recht. Should irradiation replace dissection for patients with breast cancer with clinically negative axillary lymph nodes? , 1999, Journal of surgical oncology.
[117] P. Rosen. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. , 1999, The American journal of surgical pathology.
[118] N. Segnan,et al. [Compliance, conscious participation, and informed consent in tumor screening programs]. , 1999, Epidemiologia e prevenzione.
[119] F. E. White,et al. Fine needle aspiration cytology in the UK breast screening programme: a national audit of results. , 1999, Breast.
[120] J. Austoker. Gaining informed consent for screening , 1999, BMJ.
[121] S. Ciatto,et al. Proficiency test for screening mammography: results for 117 volunteer Italian radiologists , 1999, Journal of medical screening.
[122] K. Kahn,et al. Proposed agenda for the measurement of quality-of-care outcomes in oncology practice. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] D. Jaffray,et al. A ghost story: spatio-temporal response characteristics of an indirect-detection flat-panel imager. , 1999, Medical physics.
[124] M. Overgaard,et al. Overview of randomized trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation. , 1999, Seminars in radiation oncology.
[125] J. Nottingham,et al. Invited reviewBridging the knowledge gap and communicating uncertainties for informed consent in cervical cytology screening; we need unbiased information and a culture change , 1999, Cytopathology : official journal of the British Society for Clinical Cytology.
[126] H. D. de Koning,et al. Psychosocial predictors of first attendance for organised mammography screening , 1999, Journal of medical screening.
[127] Jean-Pierre Moy,et al. How does real offset and gain correction affect the DQE in images from x-ray flat detectors? , 1999, Medical Imaging.
[128] S. Martino,et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.
[129] J. Meyer,et al. Fibrous nodules found at large-core needle biopsy of the breast: imaging features. , 1999, Radiology.
[130] C K Osborne,et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[131] R. Samant,et al. Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. , 1999, Archives of surgery.
[132] A. Hart,et al. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy , 1999, Cancer.
[133] R. Severson,et al. Axillary lymph node metastases associated with small invasive breast carcinomas , 1999, Cancer.
[134] Liesbeth Jansen,et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer , 1999, European Journal of Nuclear Medicine.
[135] G. Colditz,et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. , 1999, The New England journal of medicine.
[136] P. D. Britton,et al. Fine needle aspiration or core biopsy , 1999 .
[137] P. Britton,et al. Needle biopsy in the NHS breast screening programme 1996/97: how much and how accurate? , 1999 .
[138] A Coulter,et al. Sharing decisions with patients: is the information good enough? , 1999, BMJ.
[139] G. MacGrogan,et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS). , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[140] E. Arkin. Cancer risk communication-what we know. , 1999, Journal of the National Cancer Institute. Monographs.
[141] L. Holmberg,et al. Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. , 1999, European journal of cancer.
[142] R. Blamey. The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision). BASO Breast Specialty Group. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[143] S. Schnitt,et al. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. , 1998, The American journal of surgical pathology.
[144] C Kimme-Smith,et al. Establishing minimum performance standards, calibration intervals, and optimal exposure values for a whole breast digital mammography unit. , 1998, Medical physics.
[145] J Austoker,et al. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. , 1998, Journal of public health medicine.
[146] Mireille J. M. Broeders,et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines , 1998 .
[147] L. Beex,et al. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. , 1998, European journal of cancer.
[148] W F Velicer,et al. Increasing mammography among women aged 40-74 by use of a stage-matched, tailored intervention. , 1998, Preventive medicine.
[149] Anna L. Brown,et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[150] A Coulter,et al. Evidence based patient information , 1998, BMJ.
[151] F. Tavassoli,et al. Mammary ductal carcinoma in Situ with microinvasion , 1998, Cancer.
[152] L. G. Doak,et al. Improving comprehension for cancer patients with low literacy skills: Strategies for clinicians , 1998, CA: a cancer journal for clinicians.
[153] C. de Wolf,et al. European guidelines for quality assurance in the surgical management of mammographically detected lesions. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[154] T A Sheldon,et al. Evidence-Informed Patient Choice: Practical Issues of Involving Patients in Decisions About Health Care Technologies , 1998, International Journal of Technology Assessment in Health Care.
[155] J. Costantino,et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[156] M. Silverstein. Ductal carcinoma in situ of the breast , 1997, The British journal of surgery.
[157] E. Samei,et al. A method for measuring the presampled MTF of digital radiographic systems using an edge test device. , 1998, Medical physics.
[158] R. Gupta,et al. Fine needle aspiration cytology of tubular carcinoma of the breast. , 1997, Acta cytologica.
[159] K. Joshi,et al. Cytology of "significant" breast ductal proliferations. , 1997, Acta cytologica.
[160] A. Raffle,et al. Informed participation in screening is essential , 1997, BMJ.
[161] A. Hanlon,et al. Identification of women with T1‐T2 breast cancer at low risk of positive axillary nodes , 1997, Journal of surgical oncology.
[162] N. O’higgins,et al. Principles and guidelines for surgeons--management of symptomatic breast cancer. European Society of Surgical Oncology. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[163] I Tocino,et al. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. , 1997, Radiology.
[164] S. Shousha,et al. Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. , 1997, Journal of clinical pathology.
[165] N. O’higgins,et al. Principles and guidelines for surgeonsmanagement of symptomatic breast cancer , 1997 .
[166] W. Böcker,et al. [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis]. , 1997, Der Pathologe.
[167] H. Bartelink,et al. Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[168] R. Sainsbury,et al. Inequalities in breast cancer care and outcome. , 1997, British Journal of Cancer.
[169] N. Perry,et al. European Guidelines for Quality Assurance in Mammography Screening , 1996 .
[170] I. Fentiman,et al. Comparison of the surgical procedures for breast conserving treatment of early breast cancer in seven EORTC centres. , 1996, European journal of cancer.
[171] R. Hruban,et al. Lessons from mammographic-histopathologic correlation of large-core needle breast biopsy. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.
[172] Marshall Kg. Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs. , 1996 .
[173] N. Kapucuoglu,et al. The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer , 1996, Histopathology.
[174] R. Pinto,et al. Infarction after fine needle aspiration. A report of four cases. , 1996, Acta cytologica.
[175] M. Cunningham,et al. Factors affecting outcome of patients with impalpable breast cancer detected by breast screening , 1996, The British journal of surgery.
[176] Geraldine F. Hoemke,et al. Fundamentals of Mammography , 1996 .
[177] Barbara L. Smith,et al. Developing a prognostic index for ductal carcinoma in situ of the breast: Are we there yet? , 1996, Cancer.
[178] J. Forbes,et al. Two sequential randomized trials of community participation to recruit women for mammographic screening. , 1996, Preventive medicine.
[179] Israel Pz. The revolution in breast biopsy: where is the surgeon? , 1996 .
[180] L. Yeoman,et al. Radiographically guided fine needle aspiration cytology and core biopsy in the assessment of impalpable breast lesions , 1996 .
[181] C. Loughran,et al. Combined stereotactic wide-core needle biopsy and fine-needle aspiration cytology in the assessment of impalpable mammographic abnormalities detected in a breast-screening programme , 1996 .
[182] W. P. Evans,et al. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. , 1996, AJR. American journal of roentgenology.
[183] G. Hortobagyi,et al. Locally advanced breast cancer. , 1999, Hematology/oncology clinics of North America.
[184] C. Gillis,et al. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland , 1996, BMJ.
[185] G. Poulard,et al. [Diabetic mastopathy with epithelioid fibroblasts :differential diagnosis from an infiltrating lobular carcinoma of the breast. Report of two cases]. , 1996, Annales de pathologie.
[186] P. Israel. The revolution in breast biopsy: where is the surgeon? , 1996, The American surgeon.
[187] S. Schnitt,et al. Local control following breast-conserving surgery for invasive cancer: results of clinical trials. , 1995, Journal of the National Cancer Institute.
[188] Linda S. Lee. Fundamentals of Mammography , 1995 .
[189] S. Pinder,et al. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma , 1995, Histopathology.
[190] M. J. Silverstein,et al. Prognostic classification of breast ductal carcinoma-in-situ , 1995, The Lancet.
[191] Tavassoli Fa,et al. Pseudoinvasion in intraductal carcinoma. , 1995 .
[192] L. Liberman,et al. Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. , 1995, American journal of clinical pathology.
[193] H. Thornton. Screening for breast cancer , 1995, BMJ.
[194] R W Blamey,et al. A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. , 1995, Human pathology.
[195] P. Ganz. Advocating for the woman with breast cancer , 1995, CA: a cancer journal for clinicians.
[196] L. Liberman,et al. Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. , 1995, Radiology.
[197] F. Tavassoli,et al. Pseudoinvasion in intraductal carcinoma. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[198] C. Wells. Quality assurance in breast cancer screening cytology: a review of the literature and a report on the U.K. national cytology scheme. , 1995, European journal of cancer.
[199] U. Veronesi,et al. Surgical pitfalls after preoperative chemotherapy in large size breast cancer. , 1994, European Journal of Surgical Oncology.
[200] G. W. Eklund,et al. Percutaneous large-core breast biopsy: a multi-institutional study. , 1994, Radiology.
[201] J. Austoker,et al. Written Information Needs of Women Who are Recalled for Further Investigation of Breast Screening: Results of a Multicentre Study , 1994, Journal of medical screening.
[202] J. Chan,et al. Histologic Changes in the Breast after Fine‐Needle Aspiration , 1994, The American journal of surgical pathology.
[203] S. Levitt. The importance of locoregional control in the treatment of breast cancer and its impact on survival , 1994, Cancer.
[204] F. Tavassoli,et al. Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[205] A. Douglas-Jones,et al. Role of fine‐needle aspiration cytology and needle‐core biopsy in the diagnosis of lobular carcinoma of the breast , 1994, The British journal of surgery.
[206] M. Cranor,et al. Epithelial Displacement in Surgical Breast Specimens Following Needling Procedures , 1994, The American journal of surgical pathology.
[207] K C Young,et al. Mammographic film density and detection of small breast cancers. , 1994, Clinical radiology.
[208] D. Slamon,et al. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. , 1994, Cancer research.
[209] A. Nicholson,et al. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas , 1994, The Lancet.
[210] W. Dupont,et al. Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category. , 1994, Human Pathology.
[211] S. Pinder,et al. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up , 1994, Histopathology.
[212] L L Fajardo,et al. Stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: an analysis of 258 consecutive aspirates. , 1994, American journal of surgery.
[213] F. Abdul-Karim,et al. Mucinous lesions of the breast. A pathological continuum. , 1993, Pathology, research and practice.
[214] A. Buzdar,et al. Evaluation of patients after primary therapy for early breast cancer , 1993 .
[215] T Albert,et al. How readable are practice leaflets? , 1992, BMJ.
[216] G. Hortobagyi,et al. Treatment of locally advanced breast cancer. , 1992, Seminars in oncology.
[217] J. Meyer. Value of large-core biopsy of occult breast lesions. , 1992, AJR. American journal of roentgenology.
[218] Gini Wentz,et al. Mammography for Radiologic Technologists , 1992 .
[219] Fatteneh Ed. Tavassoli,et al. Pathology of The Breast , 1992 .
[220] L. Skoog,et al. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group. , 1992, Acta oncologica.
[221] G. W. Eklund,et al. The art of mammographic positioning. , 1992, Radiologic clinics of North America.
[222] Kunio Doi,et al. A simple method for determining the modulation transfer function in digital radiography , 1992, IEEE Trans. Medical Imaging.
[223] W. Dupont,et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. , 1991, Human pathology.
[224] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[225] D. Page. Atypical hyperplasia, narrowly and broadly defined. , 1991, Human pathology.
[226] X. Tyler,et al. Fine Needle Aspiration Cytology of Collagenous Spherulosis of the Breast , 1991, Cytopathology : official journal of the British Society for Clinical Cytology.
[227] L. Kaufman,et al. Comparison of cell growth in different parts of breast cancers , 1990, Histopathology.
[228] C. Wells,et al. Spherical connective tissue inclusions in epithelial hyperplasia of the breast ("collagenous spherulosis"). , 1990, Journal of clinical pathology.
[229] A. Evans,et al. A microglandular adenosis‐like lesion simulating tubular adenocarcinoma of the breast. A case report with cytological and histological appearances , 1990, Cytopathology : official journal of the British Society for Clinical Cytology.
[230] W. Dupont,et al. Anatomic markers of human premalignancy and risk of breast cancer , 1990, Cancer.
[231] D. Dance. Monte Carlo calculation of conversion factors for the estimation of mean glandular breast dose. , 1990, Physics in medicine and biology.
[232] M. Lagios. Duct carcinoma in situ. Pathology and treatment. , 1990, The Surgical clinics of North America.
[233] M. Silverstein,et al. Intraductal carcinoma of the breast (208 cases): Clinical factors influencing treatment choice , 1990, Cancer.
[234] I. Andersson,et al. Stereotactic fine-needle aspiration for cytologic diagnosis of nonpalpable breast lesions. , 1990, AJR. American journal of roentgenology.
[235] J. Hendriks,et al. Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ , 1990, The Lancet.
[236] R. Millis,et al. Radiation and other pathological changes in breast tissue after conservation treatment for carcinoma. , 1990, Journal of clinical pathology.
[237] K. Lindholm,et al. Aspiration cytology of tubular breast carcinoma. , 1990, Acta cytologica.
[238] N. Sneige,et al. Fine-needle aspiration cytology of metastatic neoplasms in the breast. , 1989, American journal of clinical pathology.
[239] J. Lamb,et al. Influence of cancer histology on the success of fine needle aspiration of the breast. , 1989, Journal of clinical pathology.
[240] D. Page,et al. Abstract digest , 1989, American Journal of Clinical Pathology.
[241] J. Peterse,et al. Atypia in fine-needle aspiration cytology of the breast: a histologic follow-up study of 301 cases. , 1989, Seminars in diagnostic pathology.
[242] P. Vassilakos,et al. A simple method for estrogen receptor antigen preservation in cytologic specimens containing breast carcinoma cells , 1989, Diagnostic cytopathology.
[243] R. Wood,et al. Cytodiagnosis and other methods of biopsy in the modern management of breast cancer. , 1989, Seminars in surgical oncology.
[244] R. Erlandson,et al. Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow‐up of 39 patients , 1988, Cancer.
[245] W. Dupont,et al. Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. , 1988, Human pathology.
[246] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[247] J. Lamb,et al. Fine‐needle aspiration of breast cancer: Relationship of clinical factors to cytology results in 689 primary malignancies , 1986, Cancer.
[248] P. Rosen. Mucocele-like Tumors of the Breast , 1986, The American journal of surgical pathology.
[249] E. Engelsman,et al. Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study. , 1985, International journal of radiation oncology, biology, physics.
[250] David L. Page,et al. Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study , 1985, Cancer.
[251] E. Fisher,et al. Intraductal signet ring carcinoma. A hitherto undescribed form of intraductal carcinoma of the breast , 1985, Cancer.
[252] Kenneth G. Lisk. SMPTE Test Pattern For Certification Of Medical Diagnostic Display Devices , 1984, Medical Imaging.
[253] M. Merino,et al. Intracystic papillary carcinoma of the breast after mastectomy, radiotherapy or excisional biopsy alone , 2006, Cancer.
[254] J. LoGerfo. Explorations in Quality Assessment and Monitoring. Volume I: The Definitions of Quality and Approaches to its Assessment , 1981 .
[255] C. Redmond,et al. Histologic grading of breast cancer. , 1980, Pathology annual.
[256] T. Beauchamp,et al. Principles of biomedical ethics , 1991 .
[257] E. Robecchi. [Pathology of the breast]. , 1954, Minerva ginecologica.